Assessing the most appropriate duration of dual antiplatelet therapy after coronary stenting
Tuesday, August 30, 2011 - 10:30
in Health & Medicine
A randomised multicentre open-label study evaluating the efficacy and safety of prolonged antiplatelet therapy in patients with coronary disease has found that 24 months' duration of dual therapy is no better than six months DAPT in preventing adverse cardiac events.